Physician profile
Austin Chen
NPI 1366490898
$2,786.28
in general payments reported to CMS, 2019-2025
14 companies · $36.16 in 2025
The $36.16 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $978 · 2021: $105 · 2022: $157 · 2023: $1,239 · 2024: $271 · 2025: $36.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,115 · Travel and Lodging: $431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,115.44 |
| Travel and Lodging | $431.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $978.01 | 2019 | |
| Intuitive Surgical, INC. | $730.37 | 2023 | Da Vinci Surgical System |
| Baxter Healthcare | $569.71 | 2021-2025 | Tisseel |
| Mentor Worldwide LLC | $222.27 | 2023-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Astellas Pharma US INC | $61.64 | 2023 | Veozah, Myrbetriq |
| Medtronic, INC. | $47.65 | 2023 | Interstim, Ligasure |
| Bayer Healthcare Pharmaceuticals INC. | $39.37 | 2023 | |
| Ethicon US, LLC | $33.82 | 2023 | Ethicon |
| Abbvie INC. | $21.27 | 2023 | Botox |
| Smith+Nephew, INC. | $20.00 | 2021 | |
| Merck Sharp & Dohme LLC | $18.88 | 2022 | |
| Organon LLC | $15.48 | 2023 | Nexplanon |
| Myovant Sciences INC. | $14.41 | 2022 | |
| Evofem Biosciences, INC. | $13.40 | 2023 | Phexxi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Austin Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.